72 studies found for:    Open Studies | "Pigmentation Disorders"
Show Display Options
Rank Status Study
21 Recruiting Pancreatic Cancer Early Detection Program
Conditions: Pancreatic Cancer;   Pancreas Cancer;   Pancreatic Adenocarcinoma;   Familial Pancreatic Cancer;   BRCA 1/2;   HNPCC;   Lynch Syndrome;   Hereditary Pancreatitis;   FAMMM;   Familial Atypical Multiple Mole Melanoma;   Peutz Jeghers Syndrome
Interventions: Procedure: Endoscopic Ultrasound;   Procedure: Magnetic Resonance Imaging (MRI)
22 Recruiting The Effects of Lutein and Zeaxanthin Supplementation on Vision in Patients With Albinism
Conditions: Ocular Albinism (OA);   Oculocutaneous Albinism (OCA)
Interventions: Dietary Supplement: Lutein plus Zeaxanthin;   Dietary Supplement: Placebo
23 Recruiting Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo
Condition: Vitiligo
Interventions: Procedure: Needling;   Drug: Triamcinolone
24 Recruiting A Multicenter Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)
Conditions: Vitiligo;   Piebaldism
Interventions: Device: VITICELL;   Device: PLACEBO
25 Recruiting Evaluation of an Herbal-Based De-Pigmenting System
Conditions: Melasma;   Hyperpigmentation
Interventions: Other: Herbal depigmenting agent (Epionce);   Drug: Hydroquinone
26 Recruiting Comparative Study Using Dermabrasion vs CO2 Laser & Collagen Dressing vs Vaseline Gauze in MKTP
Conditions: Vitiligo;   Depigmented Scars;   Depigmentation
Interventions: Procedure: MKTP (melanocyte keratinocyte transplant procedure);   Device: Collagen Dressing;   Device: Vaseline Impregnated Gauze;   Device: Carbon Dioxide Laser;   Device: Dermabrasion
27 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
28 Recruiting In Vivo Confocal Microscopy Study of Pigmented Conjunctival Lesions
Conditions: Nevus;   Racial Melanosis;   Primary Acquired Melanosis;   Conjunctival Malignant Melanoma
Intervention: Procedure: HRT III with Non-Contact Cornea Rostock Module
29 Recruiting Photocil (Topical) for the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Photocil for Vitiligo;   Other: Placebo - Sunscreen (SPF 2)
30 Recruiting Nitisinone for Type 1B Oculocutaneous Albinism
Conditions: Albinism;   Vision Loss
Intervention: Drug: Nitisinone (NTBC)
31 Recruiting Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions: Aggressive Systemic Mastocytosis;   Mast Cell Leukemia;   Systemic Mastocytosis
Interventions: Drug: brentuximab vedotin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
32 Recruiting Efficacy of Red Light in Vitiligo
Condition: Vitiligo
Intervention: Procedure: Red light
33 Recruiting UVA 1 Phototherapy for Vitiligo
Condition: Vitiligo
Intervention: Procedure: UVA1
34 Recruiting Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Drug: Triamcinolone Acetonide
35 Unknown  NB-UVB and PUVA Vitiligo Study
Condition: Vitiligo
Interventions: Other: Phototherapy;   Other: Phototherapy and Photochemotherapy
36 Recruiting Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
Condition: Lentigo Maligna Melanoma (Head or Neck)
Interventions: Drug: Imiquimod cream + surgery;   Drug: vehicle + surgery
37 Recruiting Vision Response to Dopamine Replacement
Conditions: Albinism;   Oculocutaneous Albinism
Intervention: Drug: Levodopa/carbidopa
38 Unknown  Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis
Condition: Advanced Systemic Mastocytosis
Intervention: Drug: Cladribine and pegylated interpheron alpha-2a
39 Unknown  Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
Condition: Vitiligo
Intervention:
40 Unknown  Efficacy and Safety of ACH24 in the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Group 01;   Drug: Group 02

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years